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CHOLERA AND CLIMATE CHANGE:
PURSUING PUBLIC HEALTH ADAPTATION STRATEGIES IN THE FACE OF SCIENTIFIC
DEBATE
Robin Kundis Craig*
ABSTRACT
Climate change will affect the prevalence, distribution, and lethality of many
diseases, from mosquito-borne diseases like malaria and dengue fever to directly
infectious diseases like influenza to water-borne diseases like cholera and
cryptosporidia. This Article focuses on one of the current scientific debates surrounding
cholera and the implications of that debate for public health-related climate change
adaptation strategies.
Since the 1970s, Rita Colwell and her co-researchers have been arguing a local
reservoir hypothesis for cholera, emphasizing that river, estuarine, and coastal waters
often contain more dormant forms of cholera attached to copepods, a form of
zooplankton. Under this hypothesis, climatically driven increases in sea surface
temperatures, sea surface levels, and phytoplankton production—such as during El Niño
years or because of climate change—can then spur cholera outbreaks in vulnerable
coastal communities. As such, the local reservoir hypothesis has immediate implications
for climate change public health adaptation strategies.
In November 2017, however, two teams of scientists published genomic research in
Science concluding that epidemic and pandemic cholera outbreaks in the Americas and
Africa originate from Asia, suggesting that the local reservoir hypothesis needs
modification. The two research articles also suggested a very different strategy for
dealing with cholera in the Anthropocene—namely, genetic detection and intensely
focused control efforts in Asia.
This Article examines in more detail this emerging scientific debate about cholera
reservoirs and the ultimate source(s) of cholera outbreaks and epidemics. It then
explores the implications of that debate for climate change public health adaptation
strategies, suggesting simultaneously that the cholera debate is one concrete example of
how identifying the stakes at issue in different climate change adaptation strategies can
help communities and nations to choose appropriate adaptation strategies despite
scientific uncertainty.
*

James I Farr Presidential Endowed Professor of Law, S.J. Quinney College of Law; affiliated faculty,
Global Change and Sustainability Center; Board, University Water Center; University of Utah, Salt Lake
City, UT. My thanks to Professor Victor Flatt for the invitation to participate in the University of Houston’s
conference entitled “Climate Change Is Making Us Sick,” held December 7, 2017, in Houston. This
research was made possible, in part, through generous support from the Albert and Elaine Borchard Fund
for Faculty Excellence. I may be contacted at robin.craig@law.utah.edu.
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INTRODUCTION:
CLIMATE CHANGE, DISEASE, AND ADAPTATION
Climate change directly and indirectly changes human health vulnerabilities,
including disease vulnerabilities. Indeed, in its 2014 Fifth Assessment, the
Intergovernmental Panel on Climate Change (IPCC) devoted an entire chapter of its
adaptation report to the human health impacts of climate change.1 It summarized that:
The health of human populations is sensitive to shifts in weather patterns
and other aspects of climate change (very high confidence). These effects
occur directly, due to changes in temperature and precipitation and
occurrence of heat waves, floods, droughts, and fires. Indirectly, health may
be damaged by ecological disruptions brought on by climate change (crop
failures, shifting patterns of disease vectors), or social responses to climate
change (such as displacement of populations following prolonged
drought).2
As is true for climate change impacts generally, a community’s vulnerability to
changing disease patterns depends on a complex mix of environmental and social factors.3
For example, “[t]he background climate-related disease rate of a population is often the
best single indicator of vulnerability to climate change—doubling of risk of disease in a
low disease population has much less absolute impact than doubling of the disease when
the background rate is high.”4 However, the changing climate itself and impacts on
environmental attributes also matter:
Climate extremes may promote the transmission of certain infectious
diseases, and the vulnerability of populations to these diseases will depend
on the baseline levels of pathogens and their vectors. In the USA, as one
example, arboviral diseases such as dengue are rarely seen after flooding,
compared with the experience in other parts of the Americas. The
explanation lies in the scarcity of dengue (and other pathogenic viruses)
circulating in the population, before the flooding. On the other hand, the
high prevalence of HIV infection in many populations in sub-Saharan
Africa will tend to multiply the health risks of climate change, due to the
interactions between chronic ill health, poverty, extreme weather events,
and undernutrition.5

1

INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, CLIMATE CHANGE 2014: IMPACTS,
AND VULNERABILITY 709-754 (2014) [hereinafter 2014 IPCC ADAPTATION REPORT].
2

Id. at 713.
Id. at 717.
4
Id.
5
Id. (citations omitted).
3
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Thus, as other researchers have emphasized, “Because most emerging disease agents are
not new but are existing pathogens of animals or humans that have been given
opportunities to infect new host populations, environmental and social changes—
especially those resulting from human activities which accelerate pathogen traffic—need
to be defined.”6
The IPCC emphasized that some of the major changes to human health that
climate change is bringing involve alterations in food-borne, water-borne, and vectorborne disease patterns.7 As such, any community’s climate change adaptation strategy
should address expected changes in these disease risks, which in turn will often depend
on climate change’s particular environmental impacts in and around that community. For
example, vector-borne diseases like malaria, dengue fever, and tick-borne encephalitis,
which are spread through insect vectors such as mosquitoes and ticks, often have complex
relationships to changes in temperature and rainfall.8 Thus, in malaria-prone regions
where climate change is pushing temperatures past mosquitoes’ maximum tolerance,
malaria may actually decrease (although heat-related health problems will increase); in
contrast, malaria is likely to increase in regions that historically have existed toward the
lower end of mosquitoes’ temperature tolerance.9 Nevertheless, globally, climate change
will probably increase significantly the number of people at risk for contracting malaria
and increase the number of areas where dengue fever can exist.10

6

Rita R. Colwell, Global Climate and Infectious Disease: The Cholera Paradigm, 274 SCIENCE 2025, 2025
(20 Dec. 1996).
7
2014 IPCC ADAPTATION REPORT, supra note 1, at 713.
8
Id. at 722-25.
9
Id. at 722 (citation omitted). These variable impacts become more pronounced at more extreme increases
in global average temperature:
Substantial warming in higher-latitude regions will open up new terrain for some infectious
diseases that are limited at present by low temperature boundaries, as already evidenced by
the northward extensions in Canada and Scandinavia of tick populations, the vectors for
Lyme disease and tick-borne encephalitis. On the other hand, the emergence of new
temperature regimes that exceed optimal conditions for vector and host species will reduce
the potential for infectious disease transmission and, with high enough temperature rise,
may eventually eliminate some infectious diseases that exist at present close to their upper
tolerable temperature limits. For example, adults of two malaria-transmitting mosquito
species are unable to survive temperatures much above 40°C in laboratory experiments,
although in the external world they may seek out tolerable microclimates. Reproduction of
the malaria parasite within the mosquito is impaired at lesser raised temperatures. Larval
development of Aedes albopictus, an Asian mosquito vector of dengue and chikungunya,
also does not occur at or above 40°C.
Id. at 736 (citations omitted).
10
Id. at 725-26.
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Cholera, in turn, is a water-borne disease and “may be transmitted by drinking
water or by environmental exposure in seawater and seafood . . . .”11 The IPCC noted in
2014 that outbreaks of cholera and infections by related Vibrio species appear to be linked
to temperature and rainfall changes in the relevant environment:
Risk of infection is influenced by temperature, precipitation, and
accompanying changes in salinity due to freshwater runoff, addition of
organic carbon or other nutrients, or changes in pH. These factors all affect
the spatial and temporal range of the organism and also influence exposure
routes (e.g., direct contact or via seafood). In countries with endemic
cholera, there appears to be a robust relationship between temperature and
the disease. In addition, heavy rainfall promotes the transmission of
pathogens when there is not secure disposal of fecal waste. An unequivocal
positive relationship between Vibrio numbers and sea surface temperature
in the North Sea has been established by DNA analyses of formalin-fixed
samples collected over a 44-year period. Cholera outbreaks have been
linked to variations in temperature and rainfall, and other variables
including sea and river levels, sea chlorophyll and cyanobacteria contents,
and Indian Ocean Dipole (IOD) and El Niño Southern Oscillation (ENSO)
event.12
While the IPCC offered no specific projections for cholera incidence in the future, its
discussion nevertheless suggested that cholera outbreaks may be more likely as
temperatures increase and heavy rainfall events become more likely.
At a very basic level, what climate change means for future disease risk, including
cholera, in a specific community depends on a number of variables, one of the most basic
of which is disease etiology—that is, disease causation, especially in terms of where
outbreaks actually come from and how they arise. Scientific debates over this etiology,
and hence the disease’s relationship to climate change, bring into sharp focus one of the
most pervasive impediments to the process of identifying and pursuing public health
climate change adaptation strategies: scientific uncertainty regarding what climate change
actually means for a given community’s or population’s disease vulnerability. Recent
discoveries about cholera’s etiology, at least for some outbreaks, have brought this
scientific uncertainty squarely into the realm of identifying cholera climate change
adaptation strategies.
This Article examines how nations should be thinking about cholera adaptation in
light of a recently sharpened and profound scientific disagreement regarding where
cholera epidemics and pandemics come from. Dr. Rita Colwell and her colleagues have
11
12

Id. at 726.
Id.
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been pursuing a local reservoir hypothesis for cholera since the 1970s, based on
discoveries that the cholera bacterium, Vibrio cholera, exists in local lakes, estuaries, and
coastal waters in conjunction with copepods, a common form of zooplankton. Under this
hypothesis, changes in climatic conditions can play a direct role in cholera outbreaks,
putting cholera prevention squarely within the subject matter of climate change
adaptation strategies. Two very recent papers in Science, in contrast, use genomic
analyses to trace all recent cholera epidemics to Asia, suggesting very different strategies
for dealing with cholera and a substantially reduced need for public health climate change
adaptation strategies.
This Article thus examines cholera as a case study example of the climate change
adaptation/scientific uncertainty conundrum. Part I presents a brief history of humanity’s
interactions with cholera, especially the seven pandemics that have ravaged the world
since the early 19th century. Part II then explains the local reservoir hypothesis of cholera
outbreaks, emphasizing how researchers working under this hypothesis have identified
environmental changes related to climate variability as both important causes and
predictors of cholera outbreaks. Part III, in turn, examines the new “Asia origin”
hypothesis and its implications for predicting and managing cholera—including the
renewed hope that cholera could be eradicated.
In Part IV, this Article examines the issue of public health climate change
adaptation strategies for cholera in light of the ongoing scientific debate over the disease’s
etiology, especially debates regarding the importance of climatic variation to cholera
outbreaks. After more specifically examining the stakes of the scientific debate over
cholera for public health measures and surveying existing strategies for dealing with
scientific uncertainty in climate change adaptation planning, it turns to four on-theground cholera prevention and treatment approaches and their places within public health
climate change adaptation policies: early warning systems for cholera outbreaks;
improved drinking water treatment and sanitation; investment in a cholera vaccine; and
efforts to eliminate cholera by eliminating its sources in Asia—a strategy that necessarily
assumes that the new science is wholly and exclusively correct. The Article concludes
that, in a world of limited resources, multi-benefit adaptation strategies such as investing
in improved drinking water and sanitation should probably take first priority in most
countries, although it acknowledges that country-specific exigencies and priorities may
justify (or allow) investment in disease-specific public health strategies such as the
cholera vaccine.
I. A BRIEF HISTORY OF CHOLERA AS A HUMAN DISEASE
A.

A Basic Overview of Cholera
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Cholera appears to have a relatively long relationship with humanity. “There are
descriptions of a disease resembling cholera in Sushruta Samshita from India, written in
Sanskrit -500 to 400 B.C. Historical records tracing back 2000 years, in both Greek and
Sanskrit, describe diseases similar to cholera.”13 The original reservoir of the cholera
bacterium, Vibrio cholera, was the Ganges River delta in India.14
Exposure to the cholera bacterium through contaminated drinking water or
shellfish leads to infection of the small intestine and diarrhea.15 Most infected people
display only mild symptoms and readily recover with no or mild treatment, although their
feces can still spread the bacterium and disease for one to ten days after infection.16
However, a minority of infected individuals “develop acute watery diarrhoea with severe
dehydration. This can lead to death if left untreated.”17
Scientists learned how to control the spread of cholera before they pinned down
its actual cause. In 1854, during the third global cholera pandemic (see below),
British physician John Snow succeeded in identifying contaminated
water as the transmitter of the disease, a breakthrough in eventually bringing
it under control.
Snow carefully mapped the cases of cholera in the Soho area in
London and traced the source to a water pump. After convincing officials
to remove the pump handle, the number of cholera cases in the area
immediately declined.18
John Snow’s discovery remains critically important to cholera prevention even today. As
the World Health Organization (WHO) emphasizes, “[p]rovision of safe water and
sanitation is critical to control the transmission of cholera . . . .”19

13

Colwell, supra note 6, at 2025.
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/
(as updated Dec. 2017).
15
Id.; D. Lippi & E. Gotuzzo, The greatest steps toward the discovery of Vibrio cholerae, 20 CLINCICAL
MICROBIOLOGY & INFECTION 191, 191 (2014).
16
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/
(as updated Dec. 2017).
17
Id.
18
CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century,
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010). For a longer
description of Snow’s investigation and discovery, see Lippi & Gotuzzo, supra note 15, at 192.
19
CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century,
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010). See also Lippi
& Gotuzzo, supra note 15, at 191 (noting that epidemic cholera “is extremely contagious in communities
without adequate sanitation.”).
14
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Connecting cholera to the Vibrio cholera bacterium, however, took a little longer.
Filippo Pacini actually discovered this bacterium in 1854, the same year as John Snow’s
epidemiological discovery.20 However, the prevailing theory of disease at the time, the
miasmal theory of disease, provided no scientific context in which to connect the
bacterium to cholera.21 However, the scientific transition to the germ theory of disease in
the later 19th century allowed Robert Koch to connect the bacterium to the disease when
he rediscovered Vibrio cholerae in 1883.22 Even then, however, skepticism over the role
of V. cholerae in causing cholera persisted until 1959, when Sambhu Nath De discovered
the bacterium’s toxin and completed the explanation of how it could cause diarrhea.23
Cholera disease occurs in three forms: endemic outbreaks, regional epidemics,
and global pandemics. As WHO notes, “[c]holera is now endemic in many countries,”
and “[a] cholera-endemic area is an area where confirmed cholera cases were detected
during the last 3 years with evidence of local transmission (meaning the cases are not
imported from elsewhere).”24 Therefore, as Parts II and III will discuss in more detail,
local reservoirs of the cholera bacterium probably remain critical sources of endemic
cholera outbreaks, which also tend to be far less lethal than the epidemic and pandemic
versions. Cholera epidemics, in turn, are a significant increase, often sudden, in cholera
cases in a specific area.25 “[E]pidemic cholera is an acute, painful and often lethal disease”
that can lead to death from dehydration in a few hours.26 Major cholera epidemics
continue to occur in South America and Africa.27 In addition, social unrest and war can
foster cholera epidemics,28 as occurred in Yemen in 2017.29
20

Lippi & Gotuzzo, supra note 15, at 191.
Id. See also id. at 193 (“Although Pacini had discovered the vibrion, his cholera data were ignored by the
scientific community and contradicted by influential physicians, who believed in the miasmatic theory,
influenced by the localist/contagionist theory of the leading German scientist Max von Pettenkoffer, who
considered cholera to be an airborne disease, caused by a combination of three factors: a germ, the local
and seasonal conditions, and a constitutional predisposition to infection” (citation omitted)).
22
Id. at 191, 193-94.
23
Id. at 194; S.N. De, Enterotoxicity of bacteria-free culture filtrate of Vibrio cholerae, 183 NATURE 1533–
1534 (1959).
24
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/
(as updated Dec. 2017).
25
See Centers for Disease Control and Prevention, Epidemic Disease Occurrence,
https://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson1/section11.html (last updated May 18, 2012)
(“Epidemic refers to an increase, often sudden, in the number of cases of a disease above what is normally
expected in that population in that area.”).
26
Lippi & Gotuzzo, supra note 15, at 191.
27
Colwell, supra note 6, at 2026.
28
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/
(as updated Dec. 2017).
29
Cholera outbreaks began in Yemen in April 2017 and, by August 2017, there were over 500,000
suspected cholera cases in that country, including almost 2000 deaths. World Health Organization, Cholera
count reaches 500 000 in Yemen, http://www.who.int/mediacentre/news/releases/2017/cholera-yemenmark/en/ (14 Aug. 2017).
21
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Finally, WHO defines a pandemic to be “the worldwide spread of a new
disease.”30 Seven cholera pandemics have occurred, 31 as the next section explains in more
detail.
B.

The Seven Cholera Pandemics

While cholera has been a human disease for over two millennia, cholera
pandemics are relatively new and date to 1817.32 Each cholera pandemic represents the
global spread of a new infectious variant of the V. cholerae bacterium, and cholera
bacteria have a wide range of genetic variations33—one reason why genomic studies like
those published in 2017 can be revealing. All recent cholera outbreaks have been caused
by the toxin-producing V. cholerae O1 serogroup.34 Within this serogroup, cholera exists
in two biotypes, classical and El Tor, and both biotypes are further classified into two
serotypes, Ogawa and Inaba.35 Classical strains of V. cholera O1 probably caused the first
six cholera pandemics, but El Tor strains are responsible for the seventh.36 “Compared
with the classical strains, El Tor persists for longer in the environment, causes more
asymptomatic cases and is shed more extensively in excreta, even in asymptomatic
cases.”37
The first cholera pandemic was the relatively limited pandemic from 1817 to
1823, which was “related to the two wars—the Oman War and the war between Persia

30

World
Health
Organization,
What
is
a
pandemic?,
http://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/en/ (24 Feb. 2010).
31
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/
(as updated Dec. 2017).
32
Colwell, supra note 6, at 2016.
33
World Health Organization, Cholera vaccines: WHO position paper, 85:13 WEEKLY EPIDEMIOLOGICAL
RECORD 117, 119 (2010) (noting that there are more than 200 serogroups of Vibrio cholerae), available at
http://www.who.int/wer/2010/wer8513.pdf?ua=1 [hereinafter 2010 WHO Cholera Vaccines Paper].
34
As WHO further explains:
There are many serogroups of V. cholerae, but only two—O1 and O139—cause outbreaks.
V. cholerae O1 has caused all recent outbreaks. V. cholerae O139—first identified in
Bangladesh in 1992—caused outbreaks in the past, but recently has only been identified in
sporadic cases. It has never been identified outside Asia. There is no difference in the
illness caused by the two serogroups.
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/ (as
updated Dec. 2017). For a more detailed discussion of the various types of V. cholera and their role in
human disease, see 2010 WHO Cholera Vaccines Paper, supra note 33, at 119.
35
2010 WHO Cholera Vaccines Paper, supra note 33, at 119.
36
Id.
37
Id. See also Colwell, supra note 6, at 2026 (“A new biovar or biotype of Vibrio cholerae caused the
current pandemic—the El Tor biotype of V. cholerae 01, which emerged in Celebes, Indonesia, in 1961.
The disease caused by this organism is usually not as severe as that of the classical biotype.”).
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and Turkey.”38 The pandemic “originated in the Ganges River delta in India,” breaking
out near Calcutta and then spreading through the rest of the country. By the early 1820s,
“colonization and trade had carried the disease to Southeast Asia, central Asia, the Middle
East, eastern Africa, and the Mediterranean coast.”39 It is difficult to know for certain
how many people died in this first pandemic, “but based on the 10,000 recorded deaths
among British troops, researchers estimate that hundreds of thousands across India
succumbed to the disease. In 1820, 100,000 people died on the Indonesian island of Java
alone. By 1823, cholera had disappeared from most of the world, except around the Bay
of Bengal.”40
The second, more widespread, pandemic of 1829 to 184941 or 185142 is sometimes
said to have begun in Russia43 but more likely began in India.44 However, if the latter, it
“reached Russia by 1830 before continuing into Finland and Poland. A two-year outbreak
began in England in October 1831 and claimed 22,000 lives.”45 Irish immigrants fleeing
the potato famine brought the disease to North America in the summer of 1832, leading
to 1,220 deaths in Montreal, Canada, and 1000 more across Quebec.46 From there, “[t]he
disease then entered the U.S. through Detroit and New York, and reached Latin America
by 1833. Another outbreak across England and Wales began in 1848, killing 52,000 over
two years.”47
The third pandemic, generally considered the most deadly of the seven, occurred
from 1852 to 1859.48 Like all but the last of the cholera pandemics, it began in India, but
it then spread to Asia, Europe, North America, and Africa.49 “In 1854, the worst year,
23,000 died in Britain alone,”50 even as John Snow was completing his pioneering
epidemiological work on cholera.
The fourth cholera pandemic occurred from 1863 to 1879. It “began in the Bengal
region [of India] from which Indian Muslim pilgrims visiting Mecca spread the disease
to the Middle East. From there it migrated to Europe, Africa and North America. At least
38

Colwell, supra note 6, at 2026.
CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century,
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010).
40
Id.
41
Id.
42
Colwell, supra note 6, at 2026.
43
Id.
44
CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century,
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010).
45
Id.
46
Id.
47
Id.
48
Id.
49
Id.
50
Id.
39
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30,000 of the 90,000 Mecca pilgrims fell victim to the disease.”51 Russia was also hard
hit: In 1866, cholera killed 90,000 Russians.52
The fifth pandemic lasted from 1881 to 1896. It “originated in the Bengal region
of India and swept through Asia, Africa, South America and parts of France and
Germany.”53 During this pandemic, 90,00 people in Japan died of the disease between
1887 and 1889, while in Russia cholera killed 200,000 people between 1893 and 1894.54
However, “[q]uarantine measures based on the findings of John Snow kept cholera out of
Britain and the United States,” and Ukrainian Waldemar Haffkine produced the first
cholera vaccine in 1892. The sixth pandemic occurred from 1899 to 1923 (some sources
say 1932) and “killed more than 800,000 in India before moving into the Middle East,
northern Africa, Russia and parts of Europe.”55
We are still living with the seventh cholera pandemic, which started in Makassar,
Sulawesi, Indonesia, in 1961 and spread to six continents,56 reaching South Asia in 1963,
Africa in 1970, Latin America in 1991, and the Caribbean (Haiti) in 2010.57 This
pandemic most affects Africa, although “little is known about the propagation routes of
cholera in this region.”58 In addition, “in 1991, 100 years after cholera was vanquished
from South America, there was an outbreak in Peru that spread across the continent,
killing 10,000 people. It was a similar strain to the seventh pandemic that petered out
more than a decade earlier.”59
C.

The Global Health Burden of Cholera

Researchers currently estimate that, “every year, there are roughly 1.3 to 4.0
million cases, and 21 000 to 143 000 deaths worldwide due to cholera.”60 According to
WHO, “Cholera remains a global threat to public health and an indicator of inequity and
lack of social development.”61
51

Id.
Id.
53
Id.
54
Id.
55
Id.
56
Dalong Hu, et al., Origins of the current seventh cholera pandemic, 113:48 PNAS E7730, E7730 (Nov.
29, 2016); Colwell, supra note 6, at 2026; World Health Organization, Cholera Fact Sheet,
http://www.who.int/mediacentre/factsheets/fs107/en/ (as updated Dec. 2017).
57
François Xavier Weill, et al., Genomic history of the seventh pandemic of cholera in Africa, 358 SCIENCE
785, 785 (10 Nov. 2017).
58
Id.
59
CBC News, Cholera’s seven pandemics: Disease has killed millions since 19th century,
http://www.cbc.ca/news/technology/cholera-s-seven-pandemics-1.758504 (Oct. 22, 2010).
60
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/
(as updated Dec. 2017); Weill et al., supra note 57, at 785.
61
World Health Organization, Cholera Fact Sheet, http://www.who.int/mediacentre/factsheets/fs107/en/
(as updated Dec. 2017).
52
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In 2010, WHO projected that cholera could become even more problematic in the
future, based in part on changing climatic conditions but also because of changes in the
disease itself:
Concerns about cholera have been heightened by the emergence of new,
apparently more virulent, strains of V. cholerae O1 that now predominate
in parts of Africa and Asia, as well as by the unpredictable emergence and
spread of antibiotic-resistant strains. Also, there is a potential for increases
in cholera outbreaks resulting from rising sea levels and increases in water
temperature, since brackish water and estuaries are natural reservoirs of V.
cholerae.62
Given this latter concern, the connections between a changing climate and its impacts
and future cholera outbreaks, epidemics, and pandemics indicate that cholera prevention
and control should be a component of many nations’ climate change adaptation
strategies. However, developing science has recently made the exact nature of those
connections between climate and disease, especially for countries not near the Bay of
Bengal, more problematic. The next two Parts discuss these contrasting hypotheses
regarding cholera etiology.
II. THE LOCAL RESERVOIR HYPOTHESIS AND CLIMATE CHANGE:
CHOLERA, COPEPODS, AND WARMING WATERS
The history of cholera pandemics presented in Part I notes that the first six
originated in India, while the last originated in Indonesia. India and Indonesia are two of
the that surround the Bay of Bengal; the others include Bangladesh, Myanmar (Burma),
and Malaysia (see Figure 1). Given this history of cholera epidemics, it is perhaps
unsurprising that researchers have focused considerable energy on the role of the Bay of
Bengal—and changes in coastal environments more generally—in the emergence of
cholera outbreaks, epidemics, and pandemics.

62

2010 WHO Cholera Vaccines Paper, supra note 33, at 119.
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Figure 1: The Bay of Bengal and Surrounding Countries. This region has been the focus of research
regarding the local reservoir hypothesis for cholera; the region has also been the starting point of all seven
cholera pandemics. Map courtesy of Quora, https://www.quora.com/about/tos and
https://qph.ec.quoracdn.net/main-qimg-e0417b691aed15d5e57a32c2f07d2890-c, and used in conformity
with its re-posting policies.

An environmental theory of cholera outbreaks pre-dated the 20th century. For
example, Robert Koch offered such a hypothesis in the late 19th century but could not
prove it “because of the ability of Vibrio cholerae, the causative agent of cholera, to enter
a dormant phase between epidemics.”63 Beginning in the 1960s, however, Dr. Rita R.
Colwell has spent decades working on the origins of cholera outbreaks and pandemics,
focusing on local reservoirs and triggering environmental conditions. In 1996 in Science,
she reported that cholera bacteria can survive in dormant states in coastal and marine
waters. Specifically, “[a]ll Vibrio spp. that are pathogenic are adapted to salinities
between 5 per mil and 30 per mil. Salinities favorable for growth of V. cholerae are found
primarily in inland coastal areas and estuaries, but the bacterium thrives in seawater as
well.”64 Cholera bacteria can survive in a dormant and non-infectious state in association
with copepods, a form of small marine zooplankton, “but apparently can be resuscitated
by heat shock.”65 In addition:
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The association of V. cholerae with zooplankton has proven to be a key
factor in deciphering the global nature of cholera epidemics. V. cholerae
preferentially attaches to chitinaceous plankton, for example, copepods, and
can be detected in zooplankton in cholera endemic regions. Ocean currents
sweeping along coastal areas thereby translocate plankton and their
bacterial passengers.66
Thus, according to Colwell, the sea and changes to the sea play an important
environmental role in cholera outbreaks and pandemics, although of course “poor
sanitation, lack of hygiene, and crowded living conditions” also play important roles in
the disease’s spread.67 Nevertheless, “[t]he history of cholera reveals a remarkably strong
association with the sea. The great pandemics followed coastlines of the world oceans.”68
Continuing research indicated that the release of dormant cholera bacteria from
copepods was linked to algal blooms (on which the copepods feed), changing sea surface
temperatures, and changing sea surface heights.69 All of these tend to occur during El
Niño events, and research published in 1999 connected cholera outbreaks in Peru to the
1997-1998 El Niño event.70 As such, the researchers concluded, advanced computational
power in combination with increased interdisciplinary understanding of the role of
copepods in cholera transmission would allow public health officials to take proactive
approaches controlling cholera outbreaks, not just reactive.71
In 2008, Colwell and a large team of researchers published a more comprehensive
assessment of the environmental factors associated with cholera epidemics in
Proceedings of the National Academy of Sciences (PNAS).72 As they noted, “Before the
late 1970s, transmission of cholera was believed to occur exclusively by person-to-person
contact, with epidemics initiated by contaminated water and food.”73 However, “[i]t is
now recognized that V. cholerae is a component of coastal and estuarine microbial
ecosystems, with the copepod species of zooplankton that comprise the aquatic fauna of
rivers, bays, estuaries and the open ocean serving as host for the bacterium.”74 Copepods
act as a vector for the disease and can each contain up to 100,000 cholera bacteria cells.75
As a result, ingestion of water containing even a few of these copepods “can initiate the
disease,” which “was demonstrated in a study showing that the number of cholera cases
66

Id.
Id.
68
Id. (citation omitted).
69
Colwell & Huq, supra note 63, at 136S.
70
Id.
71
Id. at 137S.
72
Guillaume Constantin de Magny, et al., Environmental signatures associated with cholera epidemics,
105:46 PNAS 17676, 17676-81 (Nov. 18, 2008).
73
Id. at 17676 (citations omitted).
74
Id. (citations omitted).
75
Id. (citations omitted).
67

14

Robin Kundis Craig

DRAFT

in Bangladeshi villages was significantly reduced when a simple filtration method that
effectively removed the plankton and particulate matter was used to treat drinking
water.”76
Research continued to show that copepod populations in the Bay of Bengal, and
consequent cholera epidemics, are causally linked to environmental factors, including
changes in sea surface temperatures and sea surface height.77 Later studies also
emphasized the role of precipitation and chlorophyll concentrations in the sea, which is
generally a function of algae growth and algal blooms.78 As a result, the researchers
concluded, “the variables related to copepod population dynamics can serve as a proxy
for the estimation of V. cholerae abundance in the environment.”79
Focusing on human cholera incidence in Kolkata, India, and Matlab, Bangladesh,
these researchers noted that “[e]nvironmental factors were found to be statistically
significant in [both] locations of the Indian continent in directly influencing the dynamics
of cholera epidemics.”80 However, the effect of those environmental factors were “clearly
different,” indicating that local variations are still important to cholera transmission.81
For example, Matlab is farther away from the coast than Kolkata, and human exposure
there appeared to be tied to tidal intrusion that carried increased numbers of copepods
inland to rivers and streams, where residents were the directly exposed to V. cholerae in
washing and drinking—as opposed to more direct coastal exposure in Kolkata.82 Matlab
also showed a month’s lag behind Kolkata in cholera incidence after the relevant
environmental indicators arose.83
Thus, local factors remain important to predictions of cholera incidence—and not
just environmental factors. As the researchers noted,
cholera epidemics involve a complex and critical interplay of intrinsic
dynamics with extrinsic drivers. For example, cholera is no longer a disease
threat for developed countries, including the United States, even though the
presence of V. cholerae O1 in the waters of the Chesapeake Bay and coastal
states of the Gulf of Mexico has long been known.84
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Nevertheless, the researchers’ main points for public health purposes was that
“environmental as well as epidemiological data need to be collected and compiled
expediently to provide useful and reliable predictions of the onset, epidemics, and trends
of cholera based on environmental variability” and that studies could improve cholera
predictive capacities, giving public health researchers increasing and significant lead
time to prepare a response and control strategy.85
As much of the research above indicates, Bangladesh is a cholera-endemic
country.86 Benjamin A. Cash and his colleagues, expanding upon the local reservoir
hypothesis and the postulated importance of climatic changes to cholera outbreaks and
epidemics, noted a connection between the autumn incidence of cholera in Bangladesh
and El Niño–Southern Oscillation (ENSO) events the previous winter—a potentially
important climate connection in terms of predicting cholera outbreaks and epidemics.87
ENSO affects both sea surface temperatures in the Bay of Bengal and rainfall in
Bangladesh, and above-average rainfall in turn “provid[es] a plausible physical link
between winter El Niño events and cholera incidence in Bangladesh through increased
flooding and breakdowns in sanitation.”88 The researchers noted that “the El Tor strain
of cholera replaced ‘the Classical’ strain in the environment during the mid-1970s” and
hence that their research focused purely on the El Tor strain and acknowledged that “the
two strains may respond differently to environmental drivers.”89 However, for the El Tor
strain and recent incidences of cholera, they concluded that “that Bangladesh summer
precipitation is generally higher following winter El Niño events when the warm [sea
surface temperature] anomalies in the central tropical Pacific persist through the summer
months,” establishing “a physical basis for the observed correlation between cholera
incidence and ENSO.”90 Their results, moreover, potentially allowed for improved ability
to predict cholera risk in Bangladesh, with initial predictions based on sea-surface
temperatures and the state of ENSO in the winter and then modified through monitoring
of sea surface temperature through the spring and summer.91
A year later, researchers showed that the Indian Ocean Dipole (IOD) is also
relevant to cholera outbreaks in Bangladesh.92 As these researchers reported, the IOD:
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is a climate mode arising from an ocean–atmosphere interaction that causes
interannual climate variability in the tropical Indian Ocean. A positive IOD
indicates SST [sea surface temperature] anomalies with warmer than usual
SSTs over the western basin and cooler than usual SSTs in the eastern basin
near Sumatra. A negative IOD occurs when the SST is anomalously warm
in the eastern basin and anomalously cold in the western tropical Indian
Ocean. Although the extent to which the IOD is independent of ENSO has
been debated, there is growing evidence that this air–sea interaction is
specific to the Indian Ocean.93
The IOD can also affect sea level in the Bay of Bengal and regional climate, including
monsoonal rainfall.94 Specifically, a negative IOD tends to raise sea level in the eastern
equatorial region of the Indian Ocean and to increase flooding in Bangladesh.95
As is true with other scientists working to elucidate the role of environmental
factors in cholera outbreaks, the researchers here hoped to contribute to “the development
of accurate early warning systems for cholera epidemics and aid in disease control.”96
Using a time series analysis, they concluded that a positive IOD was associated with
increased hospital visits for cholera 0-3 months later, as opposed to 8-11 months later for
ENSO events.97 They hypothesized that the IOD’s effects on rainfall upstream was
partially responsible for increased cholera incidence:
Although the causal pathways are thought to be very complicated, high river
levels/flooding are likely to be one of the important causal pathways.
Increased river levels and flooding adversely affect water sources and
sewerage systems and increase the exposure to water contaminated with V.
cholerae. The possible link between flooding and cholera may also be
associated with the growth and multiplication of V. cholerae, because
flooding increases the level of insoluble iron, which in turn improves the
survival rate of V. cholerae. It has also been suggested that flooding washes
away the vibriophages that prey on V. cholerae, resulting in increased
concentration of the bacterium in the water, although a recent simulation
study did not support this hypothesis. It is unlikely that these possible
pathways explain all cholera cases during the monsoon season, because the
incidence of cholera often dips during monsoon flooding. This dip is
thought to result from a reduction in salinity levels due to increased river
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discharge, which reduces the survival of V. cholerae and decreases its
concentration by monsoon rainfall (dilution effect).98
Despite these complexities, however, the researchers concluded that their findings
“suggest that Indian Ocean [sea surface temperature] variability should be taken into
account when building predictive models for cholera using ocean-climate data,”
including the early warning system for cholera that WHO had proposed “based on
climatic parameters.”99
As the references above to Peruvian cholera outbreaks indicate, the local reservoir
(copepod) hypothesis has also been proposed for other locations. In 2009, Colwell and
Guillaume Constantin de Magny published a more general proposal that cholera
outbreaks are related to climate.100 Noting that cholera “is reemerging in many parts of
the world in epidemic form, especially in tropical areas,” the two researchers emphasized
that “V. cholerae is naturally present in the environment,” notably in rivers, estuaries,
and coastal waters.101 As a result, they suggested, the same etiology probably applies in
all coastal nations where cholera is endemic: “At present, the main geographical regions
of cholera endemicity include coastal areas surrounding the Bay of Bengal, Bangladesh,
the Indian subcontinent, Africa, and coastal Latin America. In these regions, the same
physical or environmental drivers most likely explain the patterns of disease.”102 The
theory is relevant even to the United States, where cholera had gradually disappeared in
the early 1900s because of improved sanitation and drinking water treatment.103 The
United States is not entirely free of cholera, and “its first reappearance in the twentieth
century [was] reported in 1973 in Texas. Since then, sporadic cases are reported each
year in the United States, some of which have been confirmed as indigenous in origin.”104
Chesapeake Bay is a proven reservoir of the V. cholera bacterium, and de Magny and
Colwell developed a model to predict the presence and abundance of cholera bacteria in
that Bay.105 While the model itself is not necessary to protect public health in the
Chesapeake Bay region, it “illustrate[s] how an interdisciplinary research effort that
includes microbiology, ecology and climatology can concretize academic research to a
near-operational water-borne pathogen forecasting system.”106
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The linking of cholera outbreaks and epidemics to environmental factors—
especially factors such as precipitation, sea surface temperature, and sea surface height—
fairly directly makes continued control of cholera a climate change adaptation issue.
Indeed, researchers in this field clearly recognize the climate change connection. For
example, de Magny and Colwell pointed out in 2009 that:
The relationship between human health and climate is not a new concept,
but in the existing context of global change, when most scientists now agree
that our climate is changing, there is an increasing need to understand the
potential outcome of such changes on human health. This can be achieved
by considering how systems interact. With few exceptions, zoonotic and
vector-borne diseases are readily understood as having links with the natural
environment, and cholera is one of the best examples to illustrate this
biocomplexity.107
This research also informed the IPCC’s conclusions about the links between climate
change and human disease. As such, studies of the links between environmental factors
and cholera incidence “provide a foundation on which to build a predictive capacity for
cholera epidemics, hence, an early warning system for enhancing public health measures,
especially for developing countries and areas of the world undergoing social disruption
or climate change.”108
III. THE ASIAN DISPERSION HYPOTHESIS: IS CLIMATE REALLY RELEVANT?
As noted, although much of the research supporting the local reservoir/copepod
hypothesis regarding cholera etiology has occurred around the Bay of Bengal, researchers
claim for it a broader application to cholera’s origins. However, two genomic studies
recently published in Science call into question the ubiquity of the local reservoir
hypothesis, especially as pertains to cholera outbreaks in Africa and in Latin America.
Focusing on strains of the El Tor variety of the V. cholera bacterium, the Africa
study identified two El Tor strains “known to have invaded Africa in 1970: one in West
Africa (serotype Ogawa) and the other in East Africa (serotype Inaba).”110 The Ogawa
bacteria in Africa were related to three Chinese variations and one Indian variation, while
the Inaba serotype appears to be a mutation of the Ogawa.111 Overall, the genomic
analysis indicated that seventh-pandemic cholera that arrived in Africa in 1970 came from
South or East Asia by way of Russia and the Middle East, arriving first in Angola and
109
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then spreading to Mozambique and to Portugal and Europe as a result of Portuguese
decolonialization wars and the deployment and rotation of Portuguese troops.112
Moreover, the ten additional cholera introduction events between 1970 and 2008 all
appear to have originated in South or East Asia, with seven events involving migration
through the Middle East first and three arriving in Africa directly from Asia.113 From
these introductions into West Africa and Eastern/Southern Africa, “[e]pidemic waves
then propagated regionally, in some instances spreading to Central Africa, over periods
of a few years to 28 years . . . .”114 The genomic study could also track the cholera
bacterium’s acquisition of antibiotic resistance.115
Noting that their results are consistent with epidemiological studies of cholera in
African countries, the researchers in the African study concluded that “the human-related
factors play a much more important role in cholera dynamics in Africa than climatic and
environmental factors.”116 Specifically, “[o]ur data do not suggest that aquatic
environmental reservoirs are the primary source of epidemic cholera in Africa”; instead,
“these results highlight the role that humans play in the long-term spread and maintenance
of the pathogen, whether by direct (human-to-human) or indirect (pollution of the
environment with feces from cholera patients) transmission.”117
The Latin America study focused on the relationship “between local populations
and globally circulating pandemic lineages of V. cholerae” in the Americas, noting that
“pandemic cholera was absent from Latin America for 100 years.”118 It analyzed 252
cholera isolates from 14 countries spanning 1974 to 2014, about two-thirds of which were
seventh-pandemic El Tor varieties of cholera and about one-third of which were other
varieties.119 The strains covered pre-epidemic, epidemic, and interepidemic periods,
including the 1991 Peruvian epidemic and 2010 Haitian epidemic.120 They included both
O1 and non-O1 V. cholerae, as well as samples from both clinical and environmental
sources.121
The genomic analysis “revealed a marked diversity of V. cholerae lineages in this
region.”122 The cholera samples from the 1991 Peruvian and 2010 Haitian epidemics
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clustered in the seventh-pandemic El Tor lineages.123 Nevertheless, 11 cholera lineages
were represented in the Latin American isolates, from classical V. cholerae found in
Mexico in the mid-1990s to V. cholerae O1 local lineages to an Endemic Latin American
lineage.124 “More than 30 additional isolates sampled across Latin America do not belong
to any previously known lineage and comprise at least eight different serotypes . . . .”125
Thus, a wide range of genetic variations exist in the cholera bacteria found in
Latin America. Moreover, “[l]ocal V. cholerae O1 lineages in Latin America harbor a
wide range of genetic determinants that are associated with pandemic disease,”126 and the
discovery of classical lineages from Mexico dating from 1995 to 1997 demonstrated that
this version of the infectious bacterium had not disappeared in the 1980s, as previously
believed.127
Focusing on the seventh-pandemic El Tor lineage, however, the genomic research
showed “that the Latin American cholera epidemics were the result of multiple
intercontinental introductions . . . .”128 The strains of cholera in Latin America from the
first introduction of cholera during the seventh pandemic were most directly related to
strains from Western and Central Africa129; the strains from the second introduction were
related to strains “in South and Southeast Asia, Western Asia (Lebanon) and Eastern
Europe (Romania);130 and the strains from the third introduction were related to the
Haitian sublineage.131
However, cholera in this part of the world is more complicated than just
pandemics, and the researchers outlined “three distinct patterns of diarrheal disease
within Latin America.”132 First, some cholera lineages cause “sporadic cases or limited
outbreaks, in which secondary infections are rare or nonexistent.” While these cases are
cholera, they are far more limited in number than those generated by pandemic strains.133
“Second, lineages that occupy long-term environmental reservoirs (such as the Gulf Coast
lineage) cause illness over longer periods of time and across larger geographic areas”;
again, however, they are responsible for far fewer cases of cholera overall.134 Finally, the
“[t]hird pattern, caused by pandemic V. cholerae, is visibly distinct. Pandemic lineages
are responsible for massive, explosive epidemics that occur over short periods of time,”
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causing 20,000 cases per week in Peru in 1991 to 250,000 cases over six months in Haiti
in 2010.135
Importantly, the third pattern cases—the ones that significantly burden the public
health system—all arose (directly or indirectly) from strains of cholera bacteria that
arrived from Asia.136 Thus, like the Africa study, the Latin American study downplayed
the importance of local cholera reservoirs to the global cholera disease burden.
IV. STRATEGIES FOR CHOLERA PREVENTION IN LIGHT OF SCIENTIFIC UNCERTAINTY
AND CLIMATE CHANGE
The debate over the etiology of cholera epidemics and pandemics provides a
concrete example of a recurring issue in developing public health climate change
adaptation strategies: the problem of scientific uncertainty. This Part looks first at the
specific stakes for public health strategies of the cholera etiology debate, then reviews
general approaches to climate change adaptation planning in the face of uncertainty. It
then uses those approaches to assess four cholera-specific strategies: develop an early
warning system; improve drinking water access and treatment and basic sanitation; invest
in a cholera vaccine; and seek to control emerging cholera epidemics at their source.
A.

The Stakes of the Debate: Why Does Cholera’s Etiology Matter to a Public
Health Climate Change Adaptation Strategy?

Notably, neither of the two 2017 genomic studies of cholera study posits that
Asia-derived cholera strains are the sole source of cholera infection. The authors of the
Africa study specifically noted that their research does not exclude the possibility that
other cholera strains cause sporadic disease on that continent.137 More decisively, the
Latin American study explicitly found that there are different types and sources of cholera
in Latin America, concluding that “[a]n appreciation of the differences between pandemic
and local lineages should inform the design of disease control strategies in Latin
America.”138 Nor does either study refute (and, by affirming a southern Asian origin for
135
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many cholera pandemics, might in some ways affirm) the climate-related etiology of
cholera epidemics in Bay of Bengal countries like India and Bangalesh.
Nevertheless, as the Latin American study emphasized, epidemic and pandemic
strains of cholera impose a much greater global disease burden than the other types. As a
result, an Asian origin hypothesis for these forms of cholera outbreaks has direct
implications for where public health officials should focus their limited resources. Indeed,
the Latin America researchers discussed the stakes at issue:
[E]xploratory analyses have demonstrated since the 1970s that V. cholerae
is an integral member of many coastal, estuarine, and brackish water
ecosystems, as are other Vibrio species, in which it is often associated with
copepods and zooplankton. Accordingly, a view of V. cholerae
epidemiology emerged in the following decades, which posits that locally
evolving, but globally distributed, V. cholerae populations are responsible
for cholera outbreaks, which occur when climatic or environmental stimuli
provide favorable bacterial growth conditions in these environs. This
perception has had profound effects on all levels of global public health;
cholera is now considered to be ineradicable because its etiological agent is
ubiquitous in aquatic ecosystems.139
The Asian origin hypothesis leads to different cholera public health strategies than
the local reservoir hypothesis, particularly in terms of how to assemble early warning
systems for developing cholera epidemics and pandemics and of what the eventual global
health goal for cholera should be. With respect to early warning systems, such systems
based on the local reservoir hypothesis focus on detecting relevant changes in
environmental variables, such as sea surface temperature, sea surface height, and
chlorophyll or phytoplankton concentrations. In contrast, under the Asian origin
hypothesis, early warning systems take the form of genetic detection.140 As for the
ultimate public health goals for cholera, the local reservoir hypothesis means that cholera
can never be completely eliminated—only controlled and treated.141 In contrast, an Asian
origin means that cholera—at least in its epidemic and pandemic forms—could be
eradicated.142 Thus, the Asian origin hypothesis could lead the global public health
community to invest considerably more into Asia-centric cholera research, perhaps at the
139
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expense of learning more about complex cholera etiologies such as exist in Latin
America.
B.

General Strategies for Planning Under Uncertainty

So, where should public health officials concerned about cholera and its possible
future under climate change invest their time, adaptation efforts, and limited funding?
The costs of public health climate change adaptation strategies “may be considerable.”143
As a result, few individual nations nor the international community at large are likely to
be able to afford all-out, multi-stranded disease adaptation efforts. Under these
circumstances, the stakes at issue in adaptation choices, as well as potential multiple
benefits from certain choices, should become important factors in how the public health
sector chooses to adapt to climate change.
At the outset, public health-focused climate change adaptation strategies should
reflect well-established public health principles and a proactive approach.144 One such
principle is prevention, which can occur at three levels:
Primary prevention aims to prevent the onset of injury or illness; clinical
examples include immunization, smoking cessation efforts, and the use of
bicycle helmets. Secondary prevention aims to diagnose disease early to
control its advance and reduce the resulting health burden; clinical examples
include screening for hypertension, hyperlipidemia, and breast cancer.
Tertiary prevention occurs once disease is diagnosed; it aims to reduce
morbidity, avoid complications, and restore function.145
A second principle, and one directly related to uncertainty, is preparedness.146 New
threats such as terrorist attacks and the reemergence of infectious diseases has made the
study and anticipation of health impacts a revitalized central tenet of public health
practice, and climate change fits easily within this practice.147 Third, “[r]isk
management—systematic ongoing efforts to identify and reduce risks to health—is
another relevant framework.”148 Co-benefits offer a fourth “important framework for
public health action on climate change. Steps that address climate change frequently yield
other health benefits, both direct and indirect.”149 A fifth consideration is economics:
“Economic considerations are critical in public health planning. The mandate to
143
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maximize health protection at the lowest short-term and long-term cost is highly relevant
to climate change.”150 “Finally, ethical considerations guide public health attention to
climate change.”151
A number of general guidelines and procedures have already been proposed to
alleviate the risk planning stagnation in the face of scientific uncertainty, particularly with
respect to climate change. For example, scenario planning provides one method of
extrapolating a variety of future conditions based on varied assumptions about climatic
impacts and social and economic factors.152 “The central idea of scenario planning is to
consider a variety of possible futures that include many of the important uncertainties in
the system rather than to focus on the accurate prediction of a single outcome.”153
Scenarios may encompass realistic projections of current trends, qualitative
predictions, and quantitative models, but much of their value lies in
incorporating both qualitative and quantitative understandings of the system
and in stimulating people to evaluate and reassess their beliefs about the
system. Useful scenarios incorporate imaginative speculation and a wide
range of possibilities; those based only on what we currently know about
the system have limited power because they do not help scenario users plan
for the unpredictable.154
“Scenario planning aims to enhance our ability to respond quickly and effectively to a
wide range of futures, avoiding potential traps and benefiting from potential
opportunities.”155 The scenarios themselves are form of storytelling about the future:
“Scenarios should become brief narratives that link historical and present events with
hypothetical future events. Within these storylines the internal assumptions of the
scenario and the differences between stories must be clearly visible. To be plausible, each
scenario should be clearly anchored in the past, with the future emerging from the past
and present in a seamless way.”156 The goal of scenario planning is to enhance
institutional and individual capacity to productively respond to future change:
A successful scenario-planning effort should enhance the ability of people
to cope with and take advantage of future change. Decisions can be made,
policies changed, and management plans implemented to steer the system
toward a more desirable future. New research or monitoring activities may
150
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be initiated to increase understanding of key uncertainties, and they may
stimulate the formation of new coalitions of stakeholder groups.157
A related approach more specific to public health is vulnerability mapping.158
Vulnerability mapping can reveal potentially increasing vulnerabilities for a number of
climate change-related health impacts, including disease.159 For example, the IPCC has
applauded a number of vulnerability mapping efforts in response to climate change:
spatial modeling of geo-referenced climate and environmental information
was used to identify characteristics of domestic malaria transmission in
2009–2012 in Greece, to guide malaria control efforts. Mapping at regional
and larger scales may be useful to guide adaptation actions. In Portugal,
modeling of Lyme disease indicates that future conditions will be less
favorable for disease transmission in the south, but more favorable in the
center and northern parts of the country. This information can be used to
modify surveillance programs before disease outbreaks occur.160
Moreover, as the IPCC noted, vulnerability mapping can inform surveillance and early
warning systems, another adaptation strategy that can mitigate uncertainty.161
Once future possibilities are understood, a search for “no regrets” measures can
become an effective means of starting a climate change adaptation strategy. “No regrets”
measures are adaptation strategies that are a good idea under all or at least most future
scenarios and generally offer current benefits, as well.162 “No regrets” strategies are often
options that communities or nations should be pursuing anyway but that have been
stymied for any of several reasons—“[m]any obstacles explain the current situation,
including (i) financial and technology constraints, especially in poor countries; (ii) lack
of information and transaction costs at the micro-level; and (iii) institutional and legal
constraints.”163 Climate change adaptation can thus provide the impetus for overcoming
these obstacles. For example, as Hurricane Harvey amply demonstrated in late August
and early September 2017, toxic sites in the U.S. coastal zone pose both a current health
and safety risk and a future vulnerability in light of sea-level rise and the expected
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increasing numbers of increasingly violent coastal storms.164 As such, coastal cleanup
efforts pursuant to the federal Comprehensive Environmental Response, Compensation,
and Liability Act (CERCLA or Superfund)165 and parallel state laws qualifies as “no
regrets” climate change adaptation strategies in the United States.
“Second, it is wise to favour strategies that are reversible and flexible over
irreversible choices. The aim is to keep as low as possible the cost of being wrong about
future climate change.”166 For example, restrictive land use planning can be a helpful but
also changeable legal adaptation strategy, allowing development patterns to reflect
evolving understanding of climate change impacts in a community.167
“Third, there are ‘safety margin’ strategies that reduce vulnerability at null or low
costs.” Such strategies are often most relevant when communities or nations are
investing in new infrastructure related to climate change impacts (for example,
infrastructure to handle runoff or flooding), when building in additional capacity to
handle the worst of expected impacts generally incurs relatively small marginal costs.169
168

Institutional strategies are a fourth form of adaptation strategies.170 These
strategies, often referred to as “soft” and “timing” strategies, are usually flexible and
reversible, and they often take the form of ensuring that climate change risk assessment
and planning occur more often and at different levels of governance (international,
national, local).171 However, institutional strategies can also be financial, such as through
insurance laws or funding schemes to promote certain behaviors or investments.172
Finally, adaptation planning in the face of uncertainty requires that planners be
cognizant of potentially conflicts and synergies among adaptation strategies.173 “For
instance, an increased use of snow-making to compensate for shorter skiing seasons in
mountain areas would have negative consequences for water availability and, e.g.,
agriculture. This example shows that adaptation strategies that look profitable when
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considering only one sector may be sub-optimal at the macroeconomic scale because of
negative externalities.”174
C.

The “Preparedness” Option: Early Warning Systems for Cholera Epidemics

From a public health perspective, cholera surveillance and early warning systems
clearly serve a public health preparedness function. Most obviously, a few extra months
of warning that a cholera epidemic is likely allow public health officials time to stockpile
components for effective treatment—antibiotics, I.V. fluids, disinfectants, and so
forth.175 Moreover, in light of improved vaccines,176 early warning systems could also
allow many cases of cholera to be prevented.
Notably, researchers working under both of the cholera etiology hypotheses are
looking to develop an early warning system for cholera. However, the proposed systems
are completely different. As several researchers working under the local reservoir
hypothesis emphasize, the importance of an environmental theory of cholera etiology is
that it allows scientists to develop predictive models, based on indicator environmental
conditions, that in turn can provide warnings to public health officials regarding potential
cholera outbreaks and epidemics.177 Climatic events to be monitored for include El Nino
events,178 changes in the IOD,179 and more general environmental changes and climate
change impacts.180
In contrast, the early warning system under the Asian origin hypothesis consists
of increased genetic testing. Specifically, “When a new cholera case appears, researchers
can now sequence the bacterium to determine whether it belongs to the pandemic lineage
from Asia. That could help pinpoint truly dangerous outbreaks that most warrant use of
the limited vaccine stocks . . . .”181
These two strategies appear to require contradictory investments into both
research and public health capacity. What remains to be satisfactorily articulated,
however, is whether scientists and public health officials should pursue both
174
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approaches—i.e., whether the two types of early warning are in fact complementary and
synergistic rather than contradictory, especially with respect to the Bay of Bengal and the
countries that surround it. Until that issue can be resolved, it is probably worth pursuing
both strategies, particularly in South Asia. Genetic composition is clearly relevant to
cholera’s infectious characteristics and lethality; but, again, nothing in the two new
genomic studies directly undermines the importance of the environmental factors to the
emergence of cholera epidemics in South Asia—epidemics, if the genomic studies are
correct, that can then spread to the rest of the world.
D.

The “No Regrets” Option: Improve Drinking Water Access and Treatment
and Sanitation

According to the IPCC’s 2014 report, climate change adaptation strategies for
public health impact need to consider a variety of factors:
The degree to which programs and measures will need modification to
address additional pressures from climate change will depend on the current
burden of ill health; the effectiveness of current interventions; projections
of where, when, and how the health burden could change with climate
change; the feasibility of implementing additional programs; other stressors
that could increase or decrease resilience; and the social, economic, and
political context for intervention.182
Despite this complexity, however, “[t]he most effective measures to reduce vulnerability
in the near term are programs that implement and improve basic public health measures
such as provision of clean water and sanitation, secure essential health care including
vaccination and child health services, increase capacity for disaster preparedness and
response, and alleviate poverty (very high confidence).”183 Indeed, one of the IPCC’s
five “take-home messages” about climate change adaptation and public health in 2014
was that:
In the immediate future, accelerating public health and medical
interventions to reduce the present burden of disease, particularly diseases
in poor countries related to climatic conditions, is the single most important
step that can be taken to reduce the health impacts of climate change.
Priority interventions include improved management of the environmental
determinants of health (such as provision of water and sanitation),
infectious disease surveillance, and strengthening the resilience of health
systems to extreme weather events.184
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As cholera researchers have observed, “Because infection results from ingesting
contaminated water, cholera epidemics typically occur in regions with a limited or
damaged infrastructure.”185 Many of the studies discussed above noted that cholera no
longer occurs with any frequency in the United States and other developed countries
because these countries have safe drinking water and their citizens practice good
sanitation and hygiene—not because natural reservoirs of the V. cholerae bacterium are
lacking.186 As WHO has emphasized repeatedly, improved sanitation and drinking water
supplies are and should be the primary goal to address cholera.187
Investments in basic sanitation—clean drinking water and human waste
facilities—are “no regrets” public health climate change adaptation strategies because
such infrastructure provides multiple benefits. The statistics for clean drinking water are
somewhat encouraging: “89% of the world population used an improved drinking-water
source by end of 2011,” meaning a source protected from contamination, especially
contamination from feces.188 Nevertheless, “An estimated 768 million people did not use
an improved source for drinking-water in 2011 and 185 million relied on surface water
to meet their daily drinking-water needs.”189 Sanitation statistics are even more troubling.
According to WHO, in 2015:
•
•
•
•
•

185

2.3 billion people still do not have basic sanitation facilities such as
toilets or latrines.
Of these, 892 million still defecate in the open, for example in street
gutters, behind bushes or into open bodies of water.
At least 10% of the world’s population is thought to consume food
irrigated by wastewater.
Poor sanitation is linked to transmission of diseases such as cholera,
diarrhoea, dysentery, hepatitis A, typhoid and polio.
Inadequate sanitation is estimated to cause 280 000 diarrhoeal
deaths annually and is a major factor in several neglected tropical
diseases, including intestinal worms, schistosomiasis, and trachoma.
Poor sanitation also contributes to malnutrition.190
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In addition, the number of people lacking basic sanitation is projected to increase
throughout the 21st century in concert with generally increasing populations, and various
organizations project “that about 1.4 billion people will be without access to basic
sanitation in 2050.”191
A large factor in nations’ failure to invest in the “no regrets” options of clean
drinking water supply and waste sanitation is cost. In 2008, WHO calculated the cost of
achieving the Millennium Development Goal for drinking water and sanitation—i.e., “to
‘halve, by 2015, the proportion of people without sustainable access to safe drinking
water and basic sanitation’.”192 It estimated the total cost of new services over the
implementation period of 2005-2014 to be US$42 billion for drinking water and US$142
billion for sanitation, while the cost of maintaining existing infrastructure would be an
additional US$322 billion for water supply and US$216 billion for sanitation.193
Combined, the total investment required amounted to about US$72 billion per year over
the 10-year implementation period,194 and still, not all people would have safe drinking
water and good sanitation at the end of it.
Moreover, countries should also be ensuring that any new investment in drinking
water and sanitation infrastructure includes a “safety margin” strategy that accounts for
potentially worsening climate change impacts on water supplies and contaminating
runoff. In places where drinking water supplies are becoming increasingly vulnerable or
where extensive retrofitting may be required, however, this “safety margin” strategy
could significantly increase the costs of implementing this first, best strategy for
preventing water- and hygiene-related disease.
E.

The Prevention and Flexibility Option: The Cholera Vaccine

Improved sanitation, clean drinking water, and internalized hygiene practices are,
everyone agrees, the long-term best investment for preventing cholera—and would
improve human health more generally in a wide variety of ways. However, as noted,
drinking water and sewage treatment infrastructure are very expensive, requiring
substantial governmental, international organization, or private company investment to
build. In addition, such infrastructure investment also often comes off as, well, prosaic.
Boring. Far more exciting and newsworthy—and funding-attracting—are new and
effective treatments for an individual disease. Thus, for example, in February 2017, The
New York Times waxed poetic about a new I.V. treatment protocol for cholera “so
191
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effective that it saves 99.9 percent of all victims” of the disease and the new “effective
cholera vaccine,” enough of which may soon be stockpiled “to begin routine vaccination
is countries where the disease has a permanent foothold.”195 “The world finally has a
vaccine that, with routine administration, could end one of history’s greatest scourges,”
it concluded, although acknowledging that, “[w]ith 1.4 billion people at risk, the potential
cost of vaccination in cholera-endemic countries is enormous.”196
WHO has acknowledged the potential role of oral cholera vaccines in cholera
prevention.197 As such, cholera vaccines are among the options available to nations
pursuing cholera-specific public health climate change adaptation strategies. What
exactly that role should be, however, is an important public health and climate change
adaptation planning question, the exact answer to which is likely to vary according to the
specific risks faced by and financial circumstances of individual nations and regions.
In 2010, five different cholera vaccines existed: (1) Dukarol, an oral vaccine; (2)
Shanchol, an oral vaccine; (3) mORCVAX, an oral vaccine; (4) CVD 103- HgR, an oral,
live, attenuated single-dose vaccine that was not being produced at the time; and (5) an
injectable vaccine prepared from strains of V. cholerae made inactive with phenol.198 In
its 2010 position paper on these vaccines, WHO recommended against use of the
injectable vaccine, “mainly because of its limited efficacy and short duration of
protection.”199
With regard to the three oral cholera vaccines that remained in production in 2010,
Swedish researchers developed Dukoral and first licensed it in 1991, with over 60
countries eventually approving the vaccine for use.200 Dukoral is used “primarily as a
vaccine for travelers to cholera-endemic areas. However, it has also been used in crisis
situations in Indonesia, Sudan and Uganda, and in a demonstration project in an endemic
area of Mozambique.”201 The vaccine is relatively safe to take and was “tested in
randomized placebo-controlled double-blind prelicensure efficacy trials in both
Bangladesh and Peru”202 as well as in several other studies, including field trials.203
Moreover, because the vaccine contains a recombinant cholera toxin B subunit, it also
protects against ETEC infections.204
195
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Shanchol and mORCVAX are so similar that WHO evaluates them together.
“Unlike Dukoral, these vaccines do not contain the bacterial toxin B subunit and will
therefore not protect against ETEC.”205 Researchers licensed the original ORCVAX
vaccine in Vietnam in 1997, and “[f]rom 1998 to 2009, >20 million doses of this vaccine
were administered to children in high-risk areas of Viet Nam, making ORCVAX the first
oral cholera vaccine to be used primarily for endemic populations.”206 ORCVAX was
reformulated in 2004 to meet WHO standards, and, “[f]ollowing successful phase II trials
in India and Viet Nam, this vaccine was licensed in 2009 as mORCVAX in Viet Nam
and as Shanchol in India; mORCVAX is currently intended for domestic use in Viet Nam,
whereas Shanchol will be produced for Indian and international markets.”207
WHO concluded in 2010 that all three oral vaccines are safe and provide shortterm (about two years) protection against cholera in endemic countries.208 The vaccines
can also result in herd immunity if administered extensively in a given population, which
provides cholera protection to infants and children too young to receive the vaccine.209
Finally, while data were limited, cholera vaccine programs appeared to be costeffective.210 WHO concluded in 2010 that “[c]holera control should be a priority in areas
where the disease is endemic” and that the oral vaccines “should be used in conjunction
with other prevention and control strategies in areas where the disease is endemic and
should be considered in areas at risk for outbreaks.”211 However, WHO cautioned,
Vaccination should not disrupt the provision of other high-priority health
interventions to control or prevent cholera outbreaks. Vaccines provide a
short-term effect that can be implemented to bring about an immediate
response while the longer term interventions of improving water and
sanitation, which involve large investments, are put into place.212
Moreover, “[i]n cholera-endemic countries, vaccinating the entire population is not
warranted. Rather, vaccination should be targeted at high-risk areas and population
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groups.”213 Finally, “[p]eriodic mass vaccination campaigns are probably the most
practical option for delivering cholera vaccines.”214
WHO articulated a different role for cholera vaccines during epidemics. First,
“[p]reemptive vaccination should be considered by local health authorities to help
prevent potential outbreaks or the spread of current outbreaks to new areas.”215 Second,
during large and prolonged epidemics, “reactive vaccination could be considered by local
health authorities as an additional control measure . . . .”216 Both uses, however, required
the further development of decisionmaking tools, including risk assessment, and neither
use should displace a focus on treating individuals who develop the disease and on
improving water and sanitation.217
Dukoral (2001) and Shanchol (2011) are WHO prequalified, but mORCVAX is
not.218 The WHO prequalification program seeks to ensure that medicines, including
vaccines, purchased through or by international procurement agencies—for example,
UNICEF or the Global Fund to Fight AIDS—for distribution in resource-limited
countries meet acceptable standards of quality, safety, and efficacy.219 As a result,
prequalification status is often critical to a medicine’s or vaccine’s inclusion in global
health programs. However, prequalification is not the only consideration. With respect
to cholera vaccines, for example, Dukoral is more expensive and logistically challenging
to use than Shanchol220 because it “ha[s] to be drunk with a large glass of buffer solution
to protect it from stomach acid.”221 Given these impracticalities, Dukoral does not play a
prominent role in WHO’s recent cholera control programs.222
Two more cholera vaccines have been developed since WHO’s 2010 report. In
late 2015, WHO prequalified Euvichol, an inactivated oral cholera vaccine developed in
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the Republic of Korea.223 In 2016, the U.S. Food & Drug Administration (FDA)
approved a new version of the CVD 103-HgR attenuated virus oral vaccine known as
Vaxchora.224 Although the FDA granted Vaxchora fast track, priority review, and tropical
disease priority review225 under the Food, Drug, and Cosmetic Act,226 this new vaccine
is intended primarily for U.S. residents traveling to other countries.227 Vaxchora is not
WHO prequalified, and its effectiveness in developing countries has not been
established.228
In October 2017, WHO supported the launch of the Global Task Force on Cholera
Control, a network of United Nations and international agencies, academic institutions,
and non-governmental organizations committed to reducing world deaths from cholera
by 90 percent by 2030.229 Oral cholera vaccines are an important component of the Task
Force’s strategy, particularly in cholera “hot spots,” which include many places in
Africa.230 In particular, the Task Force advocates the “[l]arge-scale use of [oral cholera
vaccines] to immediately reduce disease burden while longer-term cholera control
strategies are put in place.”231
The Task Force’s reliance on cholera vaccines builds from the July 2013 creation
of an oral cholera vaccine stockpile and the availability of funding to subsidize the
vaccine’s cost.232 Overseen by the International Coordinating Group, the goal of the
stockpile was to make many more doses of cholera vaccines available to countries that
needed them, particularly during cholera emergencies.233 The stockpile has dramatically
increased use of cholera vaccines (Shanchol and Euvichol), from 1.4 million doses over
the 15 years from 1997 to 2012 to 13 million does administered since 2013, mostly during
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cholera emergencies.234 A record 25 million doses of the vaccines are expected to be
available in 2018.235 According to the Task Force, this increased availability of oral
cholera vaccines has become “a game-changer in the fight against cholera. It takes effect
immediately and also works to prevent cholera locally for two to three years, effectively
bridging emergency response and longer-term cholera control . . . .”236 Moreover, the
vaccine is important not only medically but also psychologically, “help[ing] to dispel the
notion that cholera is inevitable, thereby breaking the vicious cycle of inaction and
defeatism, motivating national governments and partners, and buying time to implement”
longer-term cholera control measures such as water supply and sanitation infrastructure
and hygiene practices.237
An issue remains, however: Are the cholera vaccines a permanent solution to
cholera? In 1997, “Vietnam became the first—and so far only—country to provide
cholera vaccine to its citizens routinely, not just in emergencies.”238 Cholera incidence in
Vietnam dropped sharply and disappeared from Hue in 2003.239
Nevertheless, almost all players on the international stage emphasize that cholera
vaccines, at least in their current form, are an emergency, stop-gap, and/or transitional
disease control strategy that targets cholera only—a short-term injection of prevention
and flexibility into cholera control intended to be supplanted by the longer-term and more
broadly beneficial “no regrets” measures of clean drinking water supplies and effective
sanitation. Thus, the International Coordinating Group emphasizes that:
The main objective of the oral cholera vaccine stockpile is to ensure the
timely and targeted deployment of vaccine as part of an effective outbreak
response. While vaccines provide a short-term effect as an immediate
intervention to a potential cholera outbreak, expanding access to improved
drinking-water sources and sanitation is a longer term solution for most
waterborne diseases, including cholera.240
Similarly, WHO maintains that “[i]n the long term, improvements in water supply,
sanitation, food safety and community awareness of preventive measures are the best
means of preventing cholera and other diarrhoeal diseases.”241
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The Ultimate Prevention Strategy: Can We—and Should We—Try to
Eliminate Epidemic and Pandemic Cholera at the Source?

The two 2017 Asian-origin papers in Science prompted suggestions that the
scientific and public health communities should engage in intensive efforts in South and
East Asia to eliminate the epidemic and pandemic forms of cholera at their source. One
news story, for instance, emphasized that “the [genomic] research . . . highlights the
importance of eliminating natural reservoirs of pandemic V. cholerae in Asia. . . .
Something in the region allows new strains to evolve and spread across the world, and
scientists aren’t sure what it is.”242
As with the early warning systems, the proposed strategy of hunting down the
source of epidemic and pandemic strains of cholera in Asia, particularly South Asia,
underscores the need for scientists and public health researchers to further elucidate the
exact relationship between the local reservoir hypothesis and the Asian original
hypothesis in Bay of Bengal countries. Could it be that something in the Bay of Bengal,
combined with concentrated populations in India and Bangladesh, is a laboratory for
cholera pandemics?
In the mean time, however, many countries need to weigh the costs of a potential
cholera eradication program—a disease-specific strategy—against the potentially lost
opportunity to invest in climate-resilient drinking water and sanitation infrastructure and
the plethora of public health benefits that they bring. If this is the ultimate choice that
many poor and developing nations face, then the remaining uncertainties surrounding
cholera etiology and the many co-benefits of climate-resilience water and sanitation
facilities should weigh strongly in favor of the infrastructure investments.
CONCLUSION
Climate change is already having, and will continue to have for the foreseeable
future, impacts on human health. Given limited resources, both public health norms and
strategies for dealing with uncertainty counsel in favor of investment in adaptation
strategies that provide broad preparedness and prevention advantages, allow for
additional improvements to human quality of life, fulfill human rights such as the right to
life and right to water, and help to reduce existing inequalities among populations,
including inequalities regarding who bears global health burdens.
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For all of these reasons, the scientific debate over cholera epidemic etiology
probably should not, at least for the moment, induce the global health community to rethink its basic approach to cholera disease control. Increased investment in climateresilient drinking water supplies and sanitation facilities remains a “no regrets,” multiplebenefit public health climate change adaptation strategy and should remain a first priority
for preventing water-related disease. Where cholera vaccines can bridge a public health
transition to such infrastructure or prevent the worst scourges of an epidemic, they
become a helpful supplemental strategy to the primary goal.
The dream of eradicating cholera epidemics and pandemics creates a compelling
vision of public health heroism, of science triumphing over another of humanity’s
microscopic enemies. However, in terms of allocating resources, it should always be
remembered that clean drinking water and good sanitation facilities are also very
effective at preventing cholera infections during epidemics and pandemics—and that, in
addition, they can prevent endemic cholera infection, a host of other water-borne diseases,
and water-based exposure to toxins, which an Asian eradication strategy would not. At
least in this instance, therefore, the prosaic public health adaptation strategy should win.

